| 
Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.  | 
|   | 
 | 
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology  | 
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; SERVIER; SERVIER; SERVIER; SERVIER  | 
Speakers' Bureau - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; ArQule; ArQule; ArQule; ArQule; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Sandoz; Sandoz; Sandoz; Sandoz; Servier; Servier; Servier; Servier; Takeda; Takeda; Takeda; Takeda  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Novartis; Novartis; Novartis; Novartis; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck  | 
|   | 
 | 
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer  | 
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG  | 
Research Funding - Bayer; Bayer; Bayer; Bayer  | 
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer  | 
|   | 
 | 
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck  | 
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck  | 
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Merck; Merck; Merck; Merck  | 
Research Funding - Merck; Merck; Merck; Merck  | 
Travel, Accommodations, Expenses - Regeneron; Regeneron; Regeneron; Regeneron  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
Honoraria - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech  | 
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche; Roche; Roche; Roche  | 
Research Funding - Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck  | 
|   | 
 | 
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Adaptimmune; Adaptimmune; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Onxeo; Onxeo; Onxeo; Onxeo; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Onxeo (Inst); Onxeo (Inst); Onxeo (Inst); Onxeo (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst)  | 
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Other Relationship - Medscape; Medscape; Medscape; Medscape; Target Pharmasolutions; Target Pharmasolutions; Target Pharmasolutions; Target Pharmasolutions  | 
|   | 
 | 
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca  | 
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca  | 
|   | 
 | 
Consulting or Advisory Role - Arqule; Arqule; Arqule; Arqule; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; Eisai; Eisai; Eisai; Eisai; Kowa; Kowa; Kowa; Kowa; Novartis; Novartis; Novartis; Novartis; Onxeo; Onxeo; Onxeo; Onxeo; Roche; Roche; Roche; Roche; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Speakers' Bureau - Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; BTG; BTG; BTG; BTG; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical  | 
Research Funding - Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma  | 
|   | 
 | 
No Relationships to Disclose  | 
|   | 
 | 
Consulting or Advisory Role - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Alexion Pharmaceuticals; Alexion Pharmaceuticals; Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Exelixis; Exelixis; Exelixis; Exelixis; Genentech; Genentech; Genentech; Genentech; Incyte; Incyte; Incyte; Incyte; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical  | 
Research Funding - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Incyte; Incyte; Incyte; Incyte; Lilly; Lilly; Lilly; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Newlink Genetics; Newlink Genetics; Newlink Genetics; Newlink Genetics; Polaris; Polaris; Polaris; Polaris  | 
|   | 
 | 
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Stock and Other Ownership Interests  - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
|   | 
 | 
Employment - Exelixis; Exelixis; Exelixis; Exelixis  | 
Stock and Other Ownership Interests  - Exelixis; Exelixis; Exelixis; Exelixis  | 
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent  | 
|   | 
 | 
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sanofi (I); Sanofi (I); Sanofi (I); Sanofi (I)  | 
Stock and Other Ownership Interests  - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Sanofi (I); Sanofi (I); Sanofi (I); Sanofi (I)  | 
|   | 
 | 
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
Stock and Other Ownership Interests  - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb  | 
|   | 
 | 
Honoraria - Bayer; Bayer; Bayer; Bayer; Bracco Diagnostics; Bracco Diagnostics; Bracco Diagnostics; Bracco Diagnostics; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Guerbet; Guerbet; Guerbet; Guerbet  | 
Consulting or Advisory Role - Alkermes; Alkermes; Alkermes; Alkermes; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; GE Healthcare; GE Healthcare; GE Healthcare; GE Healthcare; Siemens Healthineers; Siemens Healthineers; Siemens Healthineers; Siemens Healthineers; Tiziana Life Sciences; Tiziana Life Sciences; Tiziana Life Sciences; Tiziana Life Sciences  | 
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bracco Diagnostics; Bracco Diagnostics; Bracco Diagnostics; Bracco Diagnostics; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Guerbet; Guerbet; Guerbet; Guerbet  | 
Research Funding - Esaote; Esaote; Esaote; Esaote  | 
Travel, Accommodations, Expenses - Alkermes; Alkermes; Alkermes; Alkermes; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Siemens Healthineers; Siemens Healthineers; Siemens Healthineers; Siemens Healthineers; Tiziana Life Sciences; Tiziana Life Sciences; Tiziana Life Sciences; Tiziana Life Sciences  |